Psychopharmacology and Psychiatry Updates

265 Avsnitt

1. Association Between Mood Disorders and COVID-19

   Publicerades: 2022-06-16
2. Antidepressants and Naltrexone for Stimulant Use Disorder

   Publicerades: 2022-06-11
3. CANMAT Task Force Recommendations for the Use of Ketamine

   Publicerades: 2022-06-06
4. Stimulant Replacement Therapies for Methamphetamine and Amphetamine Use Disorder

   Publicerades: 2022-06-01
5. Premenstrual Mood Syndromes

   Publicerades: 2022-05-27
6. Stimulant Use Disorder: Diagnosis and Assessment

   Publicerades: 2022-05-22
7. Zuranolone for Postpartum Depression

   Publicerades: 2022-05-17
8. Long-Term Treatment of First Episode of Psychosis

   Publicerades: 2022-05-12
9. The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia

   Publicerades: 2022-05-07
10. Health Issues in First Episode of Psychosis

    Publicerades: 2022-05-02
11. Psychopharmacology for Treatment-Resistant Early Psychosis

    Publicerades: 2022-04-27
12. Assessing and Treating Adult ADHD

    Publicerades: 2022-04-22
13. Medications for Binge Eating Disorder

    Publicerades: 2022-04-17
14. Antipsychotics for First Episodes of Psychosis

    Publicerades: 2022-04-12
15. Effects on Suicidal Risk With Different Medications

    Publicerades: 2022-04-07
16. Risks of Using Cannabinoids

    Publicerades: 2022-04-02
17. Lithium: How to Manage Dosage

    Publicerades: 2022-03-28
18. CBD as a Medication

    Publicerades: 2022-03-23
19. SSRIs and Suicidality

    Publicerades: 2022-03-18
20. Cannabis and Cognition

    Publicerades: 2022-03-13